Abstract:We have read with interest the recent study by Le Nevé et al1Le Neve B. et al.Clin Gastroenterol Hepatol. 2016; 14: 226-233 e3Abstract Full Text Full Text PDF Scopus (34) Google Scholar that assessed visceral sensitivity and symptom severity in patients with irritable bowel syndrome (IBS) following a combined nutrient and lactulose challenge. The authors report that symptom severity assessed by validated questionnaires was significantly higher in patients with “high-intensity gastrointestinal (GI) symptoms” compared with those with “low-intensity GI symptoms” after the test meal. The high-intensity GI symptoms group also had high levels of anxiety and elevated Visceral Sensitivity Index scores (both P < .05). Furthermore, compared with the low-intensity GI symptoms group, patients in the high-intensity GI symptoms group had higher rectal sensitivity to phasic distentions administered by an electronic barostat (P < .05–.001). It is well known that patients with functional GI disorders are more likely to report food intolerance than healthy individuals.2Bohn L. et al.Am J Gastroenterol. 2013; 108: 634-641Google Scholar, 3Zheng X. et al.Neurogastroenterol Motil. 2015; 27: 1138-1146Google Scholar Indeed, the striking similarity between IBS and food intolerance symptoms suggests that malabsorption of certain foods (eg, fermentable oligosaccharides, disaccharides, monosaccharides, and polyols [FODMAP]) is an important cause of abdominal symptoms in many patients with IBS.4Shepherd S.J. et al.Clin Gastroenterol Hepatol. 2008; 6: 765-771Google Scholar, 5Halmos E.P. et al.Gastroenterology. 2014; 146: 67-75 e5Google Scholar Chemically similar to lactulose, lactose is a disaccharide FODMAP in patients with lactase deficiency. China is a country with a >95% prevalence of primary, genetic lactase deficiency6Yang J. et al.Clin Gastroenterol Hepatol. 2013; 11: 262-268 e1Google Scholar that has seen a large increase in milk consumption in recent years. This combination of genetic susceptibility and environmental challenge may have contributed to the increasing incidence of IBS documented in this population. The lactose hydrogen breath test is a simple, noninvasive investigation for the assessment of lactose absorption and tolerance. Our work in the Chinese population has shown that ingestion of 40-g lactose leads to lactose intolerance in health and disease; however, at the relatively low 20-g lactose dose, symptoms were more than 3 times more common in patients with IBS than in healthy control subjects.6Yang J. et al.Clin Gastroenterol Hepatol. 2013; 11: 262-268 e1Google Scholar In subsequent studies we applied the 20-g lactose hydrogen breath test as a clinical experimental model to identify the factors that determine the increased risk of bloating and functional GI symptoms after lactose ingestion in patients with IBS.6Yang J. et al.Clin Gastroenterol Hepatol. 2013; 11: 262-268 e1Google Scholar, 7Yang J. et al.Aliment Pharmacol Ther. 2014; 39: 302-311Google Scholar, 8Zhu Y. et al.Am J Gastroenterol. 2013; 108: 1516-1525Google Scholar Consistent with findings for the combined nutrient and lactulose challenge,1Le Neve B. et al.Clin Gastroenterol Hepatol. 2016; 14: 226-233 e3Abstract Full Text Full Text PDF Scopus (34) Google Scholar a large case-control study by Zhu et al8Zhu Y. et al.Am J Gastroenterol. 2013; 108: 1516-1525Google Scholar found that the presence of visceral hypersensitivity on rectal barostat studies increased the risk of bloating (odds ratio, 6.61; P = .005) and overall abdominal symptoms (odds ratio, 3.78; P = .014) after ingestion of 20-g lactose. Additionally, the onset of symptoms was closely related to the timing of gas production and high levels of gas production increased the risk of abdominal symptoms (odds ratio, 2.19; P = .028). The fact that Le Nevé et al1Le Neve B. et al.Clin Gastroenterol Hepatol. 2016; 14: 226-233 e3Abstract Full Text Full Text PDF Scopus (34) Google Scholar did not detect the latter effect may be caused by the larger number of subjects in the Chinese study (277 vs 100 patients with IBS). Also previous exposure to dairy products in the Chinese population may have promoted bacteria that metabolize lactose, whereas lactulose is not part of a normal diet (ie, increased sensitivity of H2 breath testing). Together these findings are consistent with the principle that both the size of the stimulus (eg, gas distention) and sensitivity to the stimulus contribute to symptom generation after FODMAP intake. The consistent finding of visceral hypersensitivity in patients with IBS with food intolerance emphasizes the importance of this pathology in functional GI disease.1Le Neve B. et al.Clin Gastroenterol Hepatol. 2016; 14: 226-233 e3Abstract Full Text Full Text PDF Scopus (34) Google Scholar, 7Yang J. et al.Aliment Pharmacol Ther. 2014; 39: 302-311Google Scholar, 8Zhu Y. et al.Am J Gastroenterol. 2013; 108: 1516-1525Google Scholar Looking ahead, FODMAP challenge tests may help to identify the causes of IBS symptoms and to direct more specific and effective therapy. Lactulose Challenge Determines Visceral Sensitivity and Severity of Symptoms in Patients With Irritable Bowel SyndromeClinical Gastroenterology and HepatologyVol. 14Issue 2PreviewPatients with irritable bowel syndrome (IBS) can be assigned to groups with different gastrointestinal (GI) symptoms based on results from a combined nutrient and lactulose challenge. We aimed to identify factors that predict outcomes to this challenge and to determine whether this can be used in noninvasive assessment of visceral sensitivity in patients with IBS. Full-Text PDF

In Vitro Efficacy of Targeted Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Enzymatic Digestion in a High-Fidelity Simulated Gastrointestinal Environment

In Vitro Effect of Enzymes and Human Milk Oligosaccharides on FODMAP Digestion and Fecal Microbiota Composition

Dietary Challenge Tests: Identifying Food Intolerance As a Cause of Symptoms in Irritable Bowel Syndrome Patients.

S818 Fodzyme at Its Finest: A Case Series Exploring a New Option for IBS Patients

Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions

Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial

Gastrointestinal tolerance of low FODMAP oral nutrition supplements in healthy human subjects: a randomized controlled trial

Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatome

All FODMAPs aren't created equal: Results of a randomized reintroduction trial in patients with irritable bowel syndrome

Effects of FODMAPs and Gluten on Gut Microbiota and Their Association with the Metabolome in Irritable Bowel Syndrome: A Double-Blind, Randomized, Cross-Over Intervention Study

Potential health benefits of lowering gas production and bifidogenic effect of the blends of polydextrose with inulin in a human gut model

SELECTION OF DIETARY FIBERS FOR GUT HEALTH BASED ON THEIR PHYSICOCHEMICAL PROPERTIES

Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial

Safety and Tolerability of Microbial Inulinase Supplementation in Healthy Adults: A Randomized, Placebo-Controlled Trial

The low-FODMAP diet for irritable bowel syndrome: Lights and shadows

Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome

Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial

Unfermented β-fructan Fibers Fuel Inflammation in Select Inflammatory Bowel Disease Patients

Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis

Long‐term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome